Upregulation of METTL14 expression can demonstrably promote the proliferation and migration of pancreatic cancer cells in an m6A-dependent manner by directly targeting the mRNA of the downstream effector PERP (the p53 effector associated with PMP-22) [123]. Here, METTL14 is linked to pancreatic neoplasm.